Samsara BioCapital’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,786,427
| Closed | -$3.84M | – | 46 |
|
|
2024
Q3 | $3.84M | Hold |
1,786,427
| – | – | 0.74% | 24 |
|
|
2024
Q2 | $9.22M | Hold |
1,786,427
| – | – | 1.93% | 15 |
|
|
2024
Q1 | $9.56M | Hold |
1,786,427
| – | – | 1.48% | 16 |
|
|
2023
Q4 | $13.9M | Buy |
1,786,427
+904,977
| +103% | +$7.05M | 2.16% | 12 |
|
|
2023
Q3 | $3.48M | Hold |
881,450
| – | – | 1.07% | 25 |
|
|
2023
Q2 | $2.78M | Hold |
881,450
| – | – | 0.49% | 26 |
|
|
2023
Q1 | $2.35M | Hold |
881,450
| – | – | 0.49% | 32 |
|
|
2022
Q4 | $3.16M | Hold |
881,450
| – | – | 0.68% | 26 |
|
|
2022
Q3 | $5.68M | Buy |
881,450
+691,488
| +364% | +$4.45M | 1.32% | 20 |
|
|
2022
Q2 | $1.83M | Hold |
189,962
| – | – | 0.49% | 36 |
|
|
2022
Q1 | $2.26M | Sell |
189,962
-28,958
| -13% | -$345K | 0.57% | 37 |
|
|
2021
Q4 | $6.24M | Hold |
218,920
| – | – | 1.21% | 19 |
|
|
2021
Q3 | $8.62M | Hold |
218,920
| – | – | 1.35% | 18 |
|
|
2021
Q2 | $10.6M | Hold |
218,920
| – | – | 1.31% | 18 |
|
|
2021
Q1 | $14.8M | Hold |
218,920
| – | – | 2.72% | 10 |
|
|
2020
Q4 | $21.8K | Buy |
218,920
+78,125
| +55% | +$7.79K | 2.2% | 6 |
|
|
2020
Q3 | $11.6M | Sell |
140,795
-16,395
| -10% | -$1.35M | 3.24% | 10 |
|
|
2020
Q2 | $15.9M | Sell |
157,190
-15,470
| -9% | -$1.56M | 5.1% | 8 |
|
|
2020
Q1 | $9.6M | Hold |
172,660
| – | – | 5.52% | 8 |
|
|
2019
Q4 | $11.3M | Hold |
172,660
| – | – | 5.39% | 7 |
|
|
2019
Q3 | $17M | Hold |
172,660
| – | – | 11.58% | 3 |
|
|
2019
Q2 | $15.2M | Buy |
172,660
+66,666
| +63% | +$5.88M | 10.06% | 4 |
|
|
2019
Q1 | $9.69M | Hold |
105,994
| – | – | 7.61% | 7 |
|
|
2018
Q4 | $5.9M | Buy |
+105,994
| New | +$5.9M | 5.67% | 7 |
|